iX Biopharma (SGX:42C) Change In Inventory : S$-0.22 Mil (TTM As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is iX Biopharma Change In Inventory?

iX Biopharma's change in inventory for the quarter that ended in Dec. 2024 was S$0.27 Mil. It means iX Biopharma's inventory declined by S$0.27 Mil from Jun. 2024 to Dec. 2024 .

iX Biopharma's change in inventory for the fiscal year that ended in Jun. 2024 was S$-0.62 Mil. It means iX Biopharma's inventory increased by S$0.62 Mil from Jun. 2023 to Jun. 2024 .

iX Biopharma's Total Inventories for the quarter that ended in Dec. 2024 was S$1.02 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. iX Biopharma's Days Inventory for the quarter that ended in Dec. 2024 was 76.06.

Inventory Turnover measures how fast the company turns over its inventory within a year. iX Biopharma's Inventory Turnover for the quarter that ended in Dec. 2024 was 2.40.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. iX Biopharma's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 0.32.

iX Biopharma Change In Inventory Historical Data

The historical data trend for iX Biopharma's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iX Biopharma Change In Inventory Chart

iX Biopharma Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Change In Inventory

Get a 7-Day Free Trial

-0.08

-0.35

-0.04

-0.20

-0.62

iX Biopharma Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Inventory	Get a 7-Day Free Trial															-0.04	-0.17	-0.13	-0.49	0.27

iX Biopharma Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was S$-0.22 Mil.

iX Biopharma (SGX:42C) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

iX Biopharma's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	1.202	/	2.884	*	365 / 2
	=	76.06

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

iX Biopharma's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	2.884	/	1.202
	=	2.40

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

iX Biopharma's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	1.202	/	3.713
	=	0.32

iX Biopharma Change In Inventory Related Terms

Thank you for viewing the detailed overview of iX Biopharma's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

iX Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » iX Biopharma Ltd (SGX:42C) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Kim Seng Promenade, No. 14-01, Great World City East Lobby, Singapore, SGP, 237994

Website

https://www.ixbiopharma.com

iX Biopharma Ltd is a Singapore-based specialty pharmaceutical and nutraceutical company focused on the development, manufacture, and commercialization of therapies for the treatment of acute and breakthrough pain, and other health conditions. Its products under development are Wafermine and BnoX for pain management, Wafesil for erectile dysfunction, WafeRest for improved sleep quality, and others. Its business segments are Specialty Pharmaceutical and Nutraceutical business segments. The firm's business segments operate in United States of America, Singapore, Australia, and China, of which the majority of the revenue comes from the United States of America. The company generates the majority of its revenue from the sale of specialty pharmaceutical products.

iX Biopharma Headlines

No Headlines